Ketamine, 3,4-Methylenedioxymethamphetamine (MDMA), and ibogaine are psychoactive substances that hold promise for psychiatric treatment alongside classic serotonergic psychedelics.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (4)

• ketamine concept
• MDMA concept
• ibogaine concept
• Serotonergic psychedelics concept